Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-inferiority trial

類似資料

• An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (NeoVanc): study protocol for a randomised controlled trial
  著者:: Louise F. Hill, 等
  出版事項: (2020-04-01)
• Detection of vanC 1 gene transcription in vancomycin-susceptible Enterococcus faecalis
  著者:: Tiane Martin de Moura, 等
  出版事項: (2013-06-01)
• Swab Testing to Optimize Pneumonia treatment with empiric Vancomycin (STOP-Vanc): study protocol for a randomized controlled trial
  著者:: Jeffrey A. Freiberg, 等
  出版事項: (2024-12-01)
• Cyrus Vance (1917-2002)
  著者:: VIRGILIO ARRAES
  出版事項: (2017-08-01)
• Vancomycin-resistance gene cluster, vanC, in the gut microbiome of acute leukemia patients undergoing intensive chemotherapy.
  著者:: Armin Rashidi, 等
  出版事項: (2019-01-01)